<?xml version="1.0" encoding="UTF-8"?>
<p>Vitamin A deficiency is highly related to measles complications and the supplementation of vitamin A has been shown to decrease the morbidity and mortality related to MeV infection in children [
 <xref rid="B59-viruses-11-01017" ref-type="bibr">59</xref>,
 <xref rid="B60-viruses-11-01017" ref-type="bibr">60</xref>,
 <xref rid="B61-viruses-11-01017" ref-type="bibr">61</xref>]. Vitamin A is also mainly used to prevent blindness due to MeV infection in children [
 <xref rid="B72-viruses-11-01017" ref-type="bibr">72</xref>,
 <xref rid="B221-viruses-11-01017" ref-type="bibr">221</xref>]. Thus, WHO recommends immediate vitamin A administration to MeV-infected children with two repeated doses of 200,000 IU especially as vitamin A deficiency is a public health problem [
 <xref rid="B3-viruses-11-01017" ref-type="bibr">3</xref>,
 <xref rid="B222-viruses-11-01017" ref-type="bibr">222</xref>,
 <xref rid="B223-viruses-11-01017" ref-type="bibr">223</xref>,
 <xref rid="B224-viruses-11-01017" ref-type="bibr">224</xref>,
 <xref rid="B225-viruses-11-01017" ref-type="bibr">225</xref>]. Nevertheless, vitamin A is also encouraged to be given in all severe cases, regardless of the country or patient age [
 <xref rid="B225-viruses-11-01017" ref-type="bibr">225</xref>]. In severe cases of measles, the combination of vitamin A with ribavirin treatment can also decrease the morbidity [
 <xref rid="B226-viruses-11-01017" ref-type="bibr">226</xref>].
</p>
